| scholarly article | Q13442814 |
| P50 | author | Lars Klareskog | Q5912759 |
| Lars Alfredsson | Q30349390 | ||
| Solbritt Rantapää Dahlqvist | Q43197602 | ||
| Marie Holmqvist | Q88175833 | ||
| Johan Askling | Q89669829 | ||
| Lennart T. H. Jacobsson | Q110625350 | ||
| Sara Wedrén | Q114337587 | ||
| P2093 | author name string | Fredrik Nyberg | |
| P2860 | cites work | Cardiovascular disease--the silent killer in rheumatoid arthritis. | Q46413169 |
| P433 | issue | 10 | |
| P921 | main subject | Sweden | Q34 |
| rheumatoid arthritis | Q187255 | ||
| heart disease | Q190805 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 2861-2869 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts | |
| P478 | volume | 60 |
| Q50135459 | Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer |
| Q38349757 | Anti-inflammatory therapies for atherosclerosis |
| Q38365624 | Atherosclerotic vascular disease in the autoimmune rheumatologic patient |
| Q36215867 | Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q33766283 | Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT) |
| Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
| Q90629334 | Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study |
| Q33859039 | Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q37829385 | Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q44887210 | Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: a case-control study |
| Q33837769 | Coherent somatic mutation in autoimmune disease |
| Q48294438 | Enhanced ventricular-arterial coupling during a 2-year physical activity programme in patients with rheumatoid arthritis: a prospective substudy of the physical activity in rheumatoid arthritis 2010 trial |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q40384936 | Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink |
| Q30009440 | IgA measurements in over 12 000 Swedish twins reveal sex differential heritability and regulatory locus near CD30L. |
| Q92122504 | Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future |
| Q35753545 | Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts |
| Q35122015 | Plasma IL-5 concentration and subclinical carotid atherosclerosis |
| Q39378053 | Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease |
| Q90454106 | Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study |
| Q35160608 | Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients |
| Q41617609 | Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q39078542 | The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis |
| Q34164644 | The immune system in atherosclerosis |
| Q44071398 | The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed? |
| Q37533298 | Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment |
| Q44293608 | Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis |
| Q84815164 | [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis] |
Search more.